Lower serum β-klotho, mBDNF, and proBDNF might indicate the development of DS in patients with SCAD and might thus represent potential diagnostic and/or therapeutic targets for patients suffering from SCAD and co-morbid depression. This evidence concerns the gene KLB and depressive symptom measurement.